Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

Description

This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).

Conditions

Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma (PAP-OP)

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

Condition
Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester
  • * Age ≥ 18
  • * Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
  • * Patient has given permission to give his/her blood/saliva sample for research testing
  • * Ability to complete questionnaire(s) by themselves or with assistance
  • * \* HPV(-) OPSCC
  • * Unable to provide informed consent
  • * Unwilling to attend screening visit at Mayo Clinic site, if indicated
  • * Unwilling/unable to complete surveys electronically

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Mayo Clinic,

Kathryn M. Van Abel, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

2027-11-01